|
HS Code |
316596 |
| Chemicalname | 3-Bromotoluene |
| Casnumber | 591-17-3 |
| Molecularformula | C7H7Br |
| Molecularweight | 171.04 |
| Appearance | Colorless to light yellow liquid |
| Boilingpoint | 184-186 °C |
| Meltingpoint | -40 °C |
| Density | 1.39 g/cm³ |
| Refractiveindex | 1.552 |
| Flashpoint | 68 °C |
| Solubilityinwater | Insoluble |
As an accredited 3-Bromotoluene factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 3-Bromotoluene is supplied in a 500 mL amber glass bottle with a secure screw cap, clearly labeled with hazard information. |
| Shipping | 3-Bromotoluene is classified as a hazardous chemical and must be shipped according to local, national, and international regulations. It is typically transported in tightly sealed containers, clearly labeled, and cushioned to prevent breakage. Shipping must comply with relevant UN numbers and require proper documentation, with handling by trained personnel only. |
| Storage | 3-Bromotoluene should be stored in a tightly closed container, in a cool, dry, well-ventilated area away from sources of ignition and incompatible substances such as strong oxidizers. Keep it away from heat, sparks, and open flame. Use proper chemical storage cabinets, clearly labeled, and ensure secondary containment to prevent spills. Store at room temperature, avoiding excessive temperatures and direct sunlight. |
Applications of 3-Bromotoluene in Industrial ManufacturingAs a manufacturer focused on specialty aromatic intermediates, we supply 3-Bromotoluene to high-value downstream segments requiring consistent purity, traceability, and documentation support. Since 3-Bromotoluene serves as a specific building block in certain value chains, this section details major industrial contexts where manufacturers integrate it into key synthesis steps and final product lines. 1. Agrochemical Active Ingredient SynthesisLeading crop protection producers use 3-Bromotoluene as a halogenated toluene intermediate during the multi-step manufacture of herbicide and fungicide active substances, including select triazine and pyridine derivatives. Our material enters the initial aryl bromination stages, supporting the precision required in regulated agrochemical routes. Downstream processors scale usage in batch or continuous reactors, optimizing ratio based on target molecule yields and impurity profiles, where documentation of compliance with hazardous substance protocols is mandatory. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Pharmaceutical Intermediate SourcingBulk pharmaceutical ingredient manufacturers draw on 3-Bromotoluene primarily as an advanced starting material for active pharmaceutical ingredient (API) intermediates within select antihypertensive and antipsychotic drug development chains. Our traceability systems and impurity documentation facilitate regulatory filings and GMP qualification. Dosage in pharma syntheses matches target step stoichiometry, with downstream QC to limit residual organobromine. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Colorant and Pigment Chemical ManufacturingProducers of high-purity organic pigments and specialty dyes utilize 3-Bromotoluene in the manufacture of arylamine, azo, and phthalocyanine colorant intermediates. Its reactivity profile supports electrophilic aromatic substitution and cross-coupling processes, often in continuous flow reactors closely monitored for environmental discharge compliance and color strength yield optimization. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Electronic Chemical Raw Material PreparationManufacturers in the electronics and display segment employ 3-Bromotoluene as a starting aromatic compound in the synthesis of specialty functional monomers and small molecules for OLED (organic light-emitting diode) and liquid crystal materials. Its brominated structure enables subsequent coupling into biphenyls and arylamines, with batch process traceability meeting critical electronics quality documentation mandates. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Specialty Chemical Custom Synthesis (Contract Manufacturing)Custom synthesis houses and contract manufacturing organizations (CMOs) choose 3-Bromotoluene as a strategically reactive building block in multi-step syntheses tailored to advanced materials research, flavors & fragrance precursors, or specialty resin development. Rigorous batch traceability, documentation for each supply lot, and adaptability to detailed customer protocols distinguish this application arena. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 3-Bromotoluene prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
In our production facilities, we dedicate a significant portion of our technical expertise and equipment to synthesizing fine aromatic compounds. 3-Bromotoluene, known to some as m-Bromotoluene, carries the CAS number 591-17-3 and the molecular formula C7H7Br. Its value to the chemical industry extends far beyond its structural simplicity. From the view of those of us working in process development and manufacturing, 3-Bromotoluene shines as a key intermediate that helps open the door to a broad series of reactions.
At its core, 3-Bromotoluene is a benzene ring bearing a bromine atom at the meta position and a methyl group at the ortho position relative to each other. Because of this specific geometry, this molecule responds distinctively to the most common reaction conditions. For synthetic chemists searching for halogenated aromatic building blocks, the subtle difference between the meta-, ortho-, and para- isomers does not go unnoticed. The bromine at the 3-position introduces reactivity patterns and selectivity different from the 2- or 4-bromotoluene analogues, a fact which those working in pharmaceutical or agrochemical R&D lean on their daily work.
From our production line to your reaction flask, high purity becomes a top priority. The specifications of our 3-Bromotoluene typically include a purity of no less than 99%, verified by gas chromatography. Moisture, substituted isomers, and residual starting materials—like toluene or dibrominated products—are closely monitored with each lot. We have learned over decades that minimizing impurities provides a smoother, more predictable outcome for the end-user, particularly for those running Grignard or lithium-halogen exchange reactions. For large-scale transformations, selectivity means less waste, easier workup, and lower raw material costs downstream.
As manufacturers with direct control over every reaction batch, we stick by a consistent set of conditions, from bromination of toluene through to purification and containment. We leverage iron or aluminum halide catalysts to encourage substitution precisely at the meta position. This approach reduces the formation of ortho and para isomers, cutting down on purification needs and improving yield. Control of temperature and feed rates makes all the difference, particularly at scale, where even slight variation in reaction conditions can affect selectivity and, consequently, product quality.
The purification doesn’t stop at distillation. Advances in fractional distillation technology, combined with column chromatography for laboratory-scale lots, let us achieve those extra few tenths of a percent in purity that researchers and plant operators often request. Packing customization, handled under an inert atmosphere, preserves the purity right through to delivery.
Chemists regularly consider whether to use the ortho, meta, or para isomer. For electrophilic substitution, the pattern of reaction is dictated in large part by the substituents already present on the ring. In the development of active pharmaceutical ingredients or advanced polymers, the choice of 3-bromotoluene over its counterparts can determine synthetic success or failure. Some routes demand selective functionalization adjacent to, or opposite, the methyl group. In some cases, we see the meta isomer serve as a starting point for nitration, giving rise to important intermediates like meta-nitrotoluene, which cannot be synthesized efficiently from the ortho or para analogs.
The subtle chemistry of bromine comes into play. Bromine acts as an excellent leaving group, which means coupling reactions—such as Suzuki, Stille, or Heck reactions—benefit from the presence of aryl bromides. Compared to chlorinated analogues, bromine exits the aromatic nucleus more readily, delivering higher conversion rates and better selectivity in many cross-coupling applications. Nonetheless, its reactivity is milder than iodine, offering balance for those who need a middle ground between cost, reactivity, and safety.
In the pharmaceutical industry, our 3-Bromotoluene routinely serves as a lynchpin intermediate, leading into routes for antihistamines, analgesics, and antipsychotics. Its structure fits directly into synthetic plans for arylated or heteroaryl products where meta-substitution enhances biological activity or changes metabolic fate. Agrochemical synthesis also leans on this material for the preparation of herbicide and pesticide scaffolds, exploiting the selectivity coming from the brominated meta position.
Our experience working with reaction engineers tells us that the compound’s reliability and reproducibility are not just buzzwords. Small impurity changes or even subtle shifts in isomeric purity can force downstream adjustments, affect product color, or change bioactivity in unpredictable ways. We have responded to this challenge with targeted process control improvements and strict batch documentation. Those changes did not happen overnight; they’ve been honed over dozens of scale-ups and commercial campaigns.
Beyond direct use, 3-Bromotoluene’s versatility in coupling chemistry stands out. In aryl-aryl bond formation—key to assembling biaryls and polyaryls found across materials science—the meta-position enables unique bond orientations that differ sharply from para- or ortho-substituted analogues. Exploratory work within our own R&D teams has shown how this property can direct ring closure or enable access to new compound classes, previously difficult to reach.
3-Bromotoluene, like many aromatic bromides, carries moderate flammability and demands thoughtful storage. We do not approach this as an afterthought. Solvent selection, closed-loop systems, and secondary containment across our facility limit the risk to personnel and minimize environmental release. Our on-site analytical laboratory performs routine air and water monitoring. These measures align with community expectations regarding chemical safety and mitigate liabilities downstream for our customers.
Waste minimization practices have evolved as regulatory standards have tightened. Modern capture and incineration systems treat vapors and liquid residues, furthering compliance and maintaining confidence in our product from both the public and our partners. Over the years, we have found process modifications that reduce byproduct formation, upgrading the selectivity of bromination reactions through in-situ monitoring and rapid quench protocols.
Market demand for halogenated toluenes usually focuses on chloro and iodo analogues. 3-Bromotoluene holds a place that neither 3-Chlorotoluene nor 3-Iodotoluene can fully occupy. Its reactivity—lying between the slow-to-activate chloro and the extremely reactive iodo compounds—gives it a unique appeal. We have found cost to play a significant role in customer choices, as bromine compounds are more expensive than chloro but generally less so than iodo.
In catalyst-laden coupling reactions, 3-chloro-variants lag far behind in conversion rate, often requiring more aggressive conditions or specialty ligands. 3-Iodotoluene, while excelling in reactivity, sometimes outpaces cost tolerances or shelf-life requirements. Our experience encouraging customers to use brominated compounds stems from field data demonstrating higher isolated yields and less catalyst decomposition compared to chlorinated routes. With improved shelf stability relative to iodo analogues, logistics teams and procurement officers tend to report lower losses during typical storage periods.
Our facility produces 3-Bromotoluene at both pilot and commercial scale, with each upscaling cycle reinforcing the importance of process control. Trace impurities—especially isomeric byproducts and heavy metals from catalytic residues—must stay below tight thresholds. In practice, that means investing in filtration, multi-stage distillation, and regular equipment cleaning. Any deviation, even at single-digit ppm, can spiral into customer dissatisfaction and unnecessary rework on the customer’s side.
Every year, client feedback and lab test results drive iterative adjustments. Modulating feedstock quality, controlling equipment temperature profiles, and retraining operators on key steps have all contributed to repeatable, clean batches. The most valuable lesson learned is this: there is no single fix. Only ongoing attention, from raw material quality through final packaging, secures the level of reliability our customers return for, campaign after campaign.
Academic researchers and industrial innovators have increasingly turned their attention to multifunctional aryl bromides for both medicinal chemistry and material science. From the manufacturer’s bench, we have witnessed novel work in OLED materials, agrochemical libraries, and even as starting points for carbon nanostructure syntheses. Continued growth in these fields ties directly to having scalable, high-grade sources of critical intermediates like 3-Bromotoluene.
Some research finds its value in substitution patterns and the fine-tuning of electronic properties on aromatic rings. In our dialogues with academic partners, access to high-purity, well-characterized 3-Bromotoluene has enabled reproducible screening results. In turn, those reliable results accelerate the development of new technologies, eliminating time wasted tracing failure back to obscure or unstable impurities.
Sustaining future production capacities requires forward-looking investment. We watch changes in regulatory control lists, new market trends in synthetic targets, and evolving green chemistry principles. This vigilance filters directly into capital plans, operator training, and infrastructure upgrades. Our team places heavy emphasis on digitization, automating sample tracking, and embedding in-line analytics into every stage of bromotoluene manufacture. These improvements do not just shave costs or improve compliance; they allow for rapid batch release, thorough lot traceability, and real-time correction of process deviations, reducing risk for both our clients and our operation.
Few other intermediates get as much attention for process optimization as halogenated aromatics. Regulatory auditors and downstream partners expect transparency, from certificate of analysis detail to sustainability reporting. Trust, continually reaffirmed, becomes the result of clear communication backed with consistent lot performance. As manufacturers, living inside the process, we understand the difference between theoretical purity and actual deliverable quality. We know that only roots-deep process discipline allows partners to scale their science with confidence.
Our team takes pride in the details that make each drum of 3-Bromotoluene distinct. The world of fine chemicals depends on this mindfulness, drawing on decades of experience, daily engagement with equipment and data, and a constant line to client needs. From the first loads of toluene in the reactors to the signed documents accompanying every outgoing shipment, we treat 3-Bromotoluene not as an abstract commodity, but as a fundamental building block, serving new therapies, advanced materials, and future discoveries. The trust our partners place in us is built on every individual decision made by real people—those who understand not only what it takes to run a reactor, but what it means to deliver on a promise, every week of every year.